KBC Group
CGON icon

KBC Group’s CG Oncology CGON Stock Holding History

KBC Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$132K Buy
1,862
+709
+61% +$52.1K ﹤0.01% 1233
2026
Q2 		$82K Hold
1,153
– – ﹤0.01% 1515
2026
Q1 		$78K Buy
+1,153
New +$65.3K ﹤0.01% 1463

Other funds holding CGON

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Renaissance Capital
Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Strengthening Families & Communities LLC
Strengthening Families & Communities LLC Boston, Massachusetts $459M AUM 29.64% 1-Year Est. Return
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

KBC Group's CGON Position: Q3 2026 in Review

KBC Group increased its CG Oncology (CGON) stake by 61% in Q3 2026, buying an estimated $52.1K and bringing the position to 1,862 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

KBC Group first reported a position in CGON in Q1 2026 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • KBC Group held 1,862 shares of CG Oncology worth $132K as of Q3 2026.
  • KBC Group bought 709 CG Oncology shares in Q3 2026, an estimated $52.1K.
  • CG Oncology made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1233 holding.
  • KBC Group first reported a position in CG Oncology in Q1 2026 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.